Get started
Author

Canming Chen

Tumor Associated Macrophage × Cancer Cell Hybrids May Acquire Cancer Stem Cell Properties in Breast Cancer
2012 · Jingxian Ding, Wei Jin, et al. · PLoS ONE · 124
PDF
Famitinib with Camrelizumab and Nab-Paclitaxel for Advanced Immunomodulatory Triple-Negative Breast Cancer (FUTURE-C-Plus): An Open-Label, Single-Arm, Phase II Trial
2022 · Li Chen, Yi-Zhou Jiang, et al. · Clinical Cancer Research · 106
PDF
The Role of Mammographic Calcification in the Neoadjuvant Therapy of Breast Cancer Imaging Evaluation
2014 · Jun-jie Li, Canming Chen, et al. · PLoS ONE · 50
PDF
Identification of a Comprehensive Spectrum of Genetic Factors for Hereditary Breast Cancer in a Chinese Population by Next-Generation Sequencing
2015 · Xiaochen Yang, Jiong Wu, et al. · PLoS ONE · 47
PDF
Estrogen receptor-related genes as an important panel of predictors for breast cancer response to neoadjuvant chemotherapy
2011 · Yizuo Chen, Canming Chen, et al. · Cancer Letters · 44
Concurrent neoadjuvant chemotherapy and estrogen deprivation in patients with estrogen receptor–positive, human epidermal growth factor receptor 2–negative breast cancer (CBCSG‐036): A randomized, controlled, multicenter trial
2019 · Ke‐Da Yu, Si‐Yu Wu, et al. · Cancer · 39
PDF
A prognostic model to predict outcome of patients failing to achieve pathological complete response after anthracycline‐containing neoadjuvant chemotherapy for breast cancer
2011 · Sheng Chen, Can‐Ming Chen, et al. · Journal of Surgical Oncology · 22
Prognostic and predictive value of Phospho-p44/42 and pAKT in HER2-positive locally advanced breast cancer patients treated with anthracycline-based neoadjuvant chemotherapy
2013 · Liang Huang, Tianwen Chen, et al. · World Journal of Surgical Oncology · 21
PDF
Efficacy and Safety of Docetaxel Combined With Oxaliplatin as a Neoadjuvant Chemotherapy Regimen for Chinese Triple-Negative Local Advanced Breast Cancer Patients
2012 · Fei Fei, Canming Chen, et al. · American Journal of Clinical Oncology · 21
The clinicopathological and MRI features of patients with BRCA1/2 mutations in familial breast cancer
2021 · Chao You, Qin Xiao, et al. · Gland Surgery · 19
PDF
Comprehensive circRNA Expression Profile and Construction of circRNAs-Related ceRNA Network in a Mouse Model of Autism
2021 · Ji Wang, Zhongxiu Yang, et al. · Frontiers in Genetics · 15
PDF
Quality of Life and Psychological State in Chinese Breast Cancer Patients Who Received BRCA1/2 Genetic Testing
2016 · Jiajia Qiu, Jiaqin Guan, et al. · PLoS ONE · 14
PDF
Combination of famitinib with camrelizumab plus nab-paclitaxel as first-line treatment for patients with immunomodulatory advanced triple-negative breast cancer (FUTURE-C-PLUS): A prospective, single-arm, phase 2 study.
2021 · Li Chen, Shao Zhimin, et al. · Journal of Clinical Oncology · 12
E2F‐1‐ and E2Ftr‐mediated apoptosis: the role of DREAM and HRK
2011 · Hongying Hao, Canming Chen, et al. · Journal of Cellular and Molecular Medicine · 11
PDF
Comprehensive recycling of fresh municipal sewage sludge to fertilize garden plants and achieve low carbon emission: A pilot study
2022 · Xianke Lin, Canming Chen, et al. · Frontiers in Environmental Science · 10
Phytoextraction and Migration Patterns of Cadmium in Contaminated Soils by Pennisetum hybridum
2023 · Canming Chen, Zebin Wei, et al. · Plants · 8
PDF
Hyperspectral Inversion Model of Relative Heavy Metal Content in Pennisetum sinese Roxb via EEMD-db3 Algorithm
2023 · Ting Tang, Canming Chen, et al. · Remote Sensing · 6
PDF
Induction of Apoptosis Signal-Regulating Kinase 1 by E2F-1 May Not Be Essential for E2F-1-Mediated Apoptosis in Melanoma Cells
2007 · Yan Bin Dong, Allison M. Phelps, et al. · Tumor Biology · 6
Abstract P1-12-02: Effect of using LHRH analog during chemotherapy (CT) on premature ovarian failure and prognosis in premenopausal patients with early-stage, hormone receptor-positive breast cancer: The primary analysis of a randomized controlled phase III trial
2015 · Jian-Wei Li, Guang-yu Liu, et al. · Cancer Research · 5
The overall survival analysis of FUTURE-C-PLUS: Combination of famitinib with camrelizumab plus nab-paclitaxel as first-line treatment for advanced, immunomodulatory triple-negative breast cancer—An open-label, single-arm, phase 2 trial.
2023 · Li Chen, Shao Zhimin, et al. · Journal of Clinical Oncology · 4
PDF
[Analysis of DFNA5 gene variant in a Chinese pedigree affected with late-onset non-syndromic hearing loss].
2021 · Nuoyang Wang, Canming Chen, et al. · PubMed · 3
[Genetic analysis of a pedigree affected with congenital split-hand/foot malformation].
2020 · Qian Li, Ming Tong, et al. · PubMed · 2
A Design of Mandibular Motion Tracking System Based on Video Processing
2019 · Tongsheng Tang, Mingcheng Zhu, et al. · IEEE Advanced Information Technology, Electronic and Automation Control Conference (IAEAC) · 2
[Germline mutations of TP53 gene among Chinese families with high risk for breast cancer].
2015 · Xiaochen Yang, Zhen Hu, et al. · PubMed · 2
[A study on the relationship between breast cancer molecular classification and prognosis].
2008 · Xiao-Song Chen, Chuan-Dong Ma, et al. · PubMed · 2
Works count: 43
Citation count: 598
H-index: 12
I10-index: 15
Year
Topic
Type